Help us fund research to slow, stop and reverse Parkinson’s
CPT's President Tom Isaacs has used his networking powers to help engage a stellar list of renowned contemporary artists to create individual pieces of work to raise funds for The Cure Parkinson's Trust. Read more
Researchers at Johns Hopkins have two important new clues in the fight against Parkinson's: blocking an enzyme prevents the disease in mice and a chemical tag on a second protein may signal the disorder's presence. Read more
Our 2016 Annual Review is here! We reflect on another full and productive year. Whilst there is more we can do, and indeed must do, we are proud of our achievements over the past year. Read more
The City-based philanthropy group, The October Club has chosen The Cure Parkinson’s Trust as the beneficiary charity for their annual fundraising dinner. Read more
Naga Munchetty and James Haggar hosted the Batchworth Golf Club Foxes Invitation Meeting. James is presiding over his year of captaincy at the club and The Cure Parkinson's Trust is delighted to be his chosen beneficiary charity. Read more
A postmortem examination of a patient with Parkinson's who underwent dopaminergic cell transplantation 24 years ago has shown that the transplanted neurons had reinnervated the brain for all that time. Read more
The 28th Gulls’ Eggs Luncheon, held on Tuesday 10th May 2016, at Merchant Taylors’ Hall, attracted over 550 guests, who helped raise over £55,000 (net) for The Cure Parkinson’s Trust. Read more
A research paper published in the Journal of Parkinson's Disease (Spring 2016) discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells. Read more
On Sunday 24th April, CPT's team of dedicated runners hit the streets of London in support of our research. We can't thank them enough for their mammoth efforts over these past months and, of course, that huge feat yesterday! Read more
BBC News Anchor, Sophie Raworth, chose to run the Virgin Money London Marathon in support of the work of The Cure Parkinson's Trust following her father's Parkinson's diagnosis. Read more
Marathon motivation: Garth Ravenhill, was diagnosed with Parkinson's 7 years ago. As Garth has not taken part in any race further than 10k before he is unsure how his body is going to cope but is determined to finish the London Marathon. Read more
Researchers at La Trobe University in Australia have developed a world-first diagnostic blood test which could change the lives of people with Parkinson's disease. Read more
We mark World Parkinson's Day 2016 with the results of a survey we recently conducted. Read more... Read more
Sir Richard Nichols, Co-founder, former Chairman and Trustee of The Cure Parkinson’s Trust. Read more
Researchers have demonstrated that a decrease in polyunsaturated lipids in neuronal membranes, as seen in Parkinson's sufferers, directly affects the binding rate of dopamine and adenosine receptors. Read more
Seven of the world’s largest pharmaceutical companies have signed up to a ground-breaking consortium aimed at accelerating the development of safe and effective therapies for Parkinson’s. Read more
Can a smartphone unlock new discoveries in Parkinson’s? This people-centred project is open to everyone so please do get involved! Read more
A medication approved to treat various respiratory diseases and that has demonstrated neuroprotective effects in preclinical studies is the focus of a new clinical trial for Parkinson’s disease. Read more
Called the Parkinson Power Through Project (PTP), Brian Grant - NBA basketball star, urges all people with Parkinson's to incorporate exercise into their daily routine to help them live life to the fullest. Read more
Dr Richard Wyse is a keynote speaker at this month's World CNS Summit in Boston. Dr Wyse was interviewed prior to the conference about the challenges in developing drugs for Parkinson's and his views on the current research pipeline. Read more
CPT is delighted to receive a grant from the Garfield Weston Foundation. This funding will be put towards a sub-study currently being run alongside the Simvastatin trial. Read more